304 related articles for article (PubMed ID: 7970709)
21. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
22. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells.
Kolch W; Heidecker G; Lloyd P; Rapp UR
Nature; 1991 Jan; 349(6308):426-8. PubMed ID: 1992343
[TBL] [Abstract][Full Text] [Related]
23. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
Blasi E; Radzioch D; Merletti L; Varesio L
Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
[TBL] [Abstract][Full Text] [Related]
24. Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells.
Cosgaya JM; Aranda A
Oncogene; 1996 Jun; 12(12):2651-60. PubMed ID: 8700524
[TBL] [Abstract][Full Text] [Related]
25. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
Kim S; Brown PH; Birrer MJ
Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
[TBL] [Abstract][Full Text] [Related]
26. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
27. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.
Cox AD; Brtva TR; Lowe DG; Der CJ
Oncogene; 1994 Nov; 9(11):3281-8. PubMed ID: 7936652
[TBL] [Abstract][Full Text] [Related]
28. While E1A can facilitate epithelial cell transformation by several dominant oncogenes, the C-terminus seems only to regulate rac and cdc42 function, but in both epithelial and fibroblastic cells.
Fischer RS; Quinlan MP
Virology; 2000 Apr; 269(2):404-19. PubMed ID: 10753719
[TBL] [Abstract][Full Text] [Related]
29. Expression of growth-related genes during tumor progression in v-raf-transformed rat liver epithelial cells.
Hampton LL; Worland PJ; Yu B; Thorgeirsson SS; Huggett AC
Cancer Res; 1990 Dec; 50(23):7460-7. PubMed ID: 1701345
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
[TBL] [Abstract][Full Text] [Related]
32. v-Ras and v-Raf block differentiation of transformable C3H10T1/2-derived preadipocytes at lower levels than required for neoplastic transformation.
Raptis L; Brownell HL; Lu Y; Preston T; Narsimhan RP; Anderson S; Schaefer E; Haliotis T
Exp Cell Res; 1997 Aug; 235(1):188-97. PubMed ID: 9281368
[TBL] [Abstract][Full Text] [Related]
33. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
34. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
Douvdevani A; Huleihel M; Segal S; Apte RN
Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
[TBL] [Abstract][Full Text] [Related]
35. Biological activity of human N-ras and K-ras genes containing the Asn17 dominant negative mutation.
Kaplan JB
Oncol Res; 1994; 6(12):611-5. PubMed ID: 7787254
[TBL] [Abstract][Full Text] [Related]
36. v-erbA oncogene abrogates growth inhibition of chicken embryo fibroblasts induced by retinoic acid.
Desbois C; Pain B; Guilhot C; Benchaibi M; Ffrench M; Ghysdael J; Madjar JJ; Samarut J
Oncogene; 1991 Nov; 6(11):2129-35. PubMed ID: 1682867
[TBL] [Abstract][Full Text] [Related]
37. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
Cacace AM; Ueffing M; Philipp A; Han EK; Kolch W; Weinstein IB
Oncogene; 1996 Dec; 13(12):2517-26. PubMed ID: 9000126
[TBL] [Abstract][Full Text] [Related]
38. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
39. The c-Mos proto-oncogene product stimulates c-Jun transcriptional activity by a MAP kinase-dependent mechanism.
Sever R; Turner R
Biochem Biophys Res Commun; 1996 Nov; 228(2):259-66. PubMed ID: 8920903
[TBL] [Abstract][Full Text] [Related]
40. Oxamflatin: a novel compound which reverses malignant phenotype to normal one via induction of JunD.
Sonoda H; Nishida K; Yoshioka T; Ohtani M; Sugita K
Oncogene; 1996 Jul; 13(1):143-9. PubMed ID: 8700540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]